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Microbial biosynthesis of lactate esters
Jong‑Won Lee1,2 and Cong T. Trinh1,2,3* 
Abstract 
Background: Green organic solvents such as lactate esters have broad industrial applications and favorable envi‑
ronmental profiles. Thus, manufacturing and use of these biodegradable solvents from renewable feedstocks help 
benefit the environment. However, to date, the direct microbial biosynthesis of lactate esters from fermentable sugars 
has not yet been demonstrated.
Results: In this study, we present a microbial conversion platform for direct biosynthesis of lactate esters from 
fermentable sugars. First, we designed a pyruvate‑to‑lactate ester module, consisting of a lactate dehydrogenase 
(ldhA) to convert pyruvate to lactate, a propionate CoA‑transferase (pct) to convert lactate to lactyl‑CoA, and an 
alcohol acyltransferase (AAT ) to condense lactyl‑CoA and alcohol(s) to make lactate ester(s). By generating a library of 
five pyruvate‑to‑lactate ester modules with divergent AATs, we screened for the best module(s) capable of produc‑
ing a wide range of linear, branched, and aromatic lactate esters with an external alcohol supply. By co‑introducing 
a pyruvate‑to‑lactate ester module and an alcohol (i.e., ethanol, isobutanol) module into a modular Escherichia coli 
(chassis) cell, we demonstrated for the first time the microbial biosynthesis of ethyl and isobutyl lactate esters directly 
from glucose. In an attempt to enhance ethyl lactate production as a proof‑of‑study, we re‑modularized the pathway 
into (1) the upstream module to generate the ethanol and lactate precursors and (2) the downstream module to 
generate lactyl‑CoA and condense it with ethanol to produce the target ethyl lactate. By manipulating the metabolic 
fluxes of the upstream and downstream modules through plasmid copy numbers, promoters, ribosome binding sites, 
and environmental perturbation, we were able to probe and alleviate the metabolic bottlenecks by improving ethyl 
lactate production by 4.96‑fold. We found that AAT is the most rate‑limiting step in biosynthesis of lactate esters likely 
due to its low activity and specificity toward the non‑natural substrate lactyl‑CoA and alcohols.
Conclusions: We have successfully established the biosynthesis pathway of lactate esters from fermentable sugars 
and demonstrated for the first time the direct fermentative production of lactate esters from glucose using an E. coli 
modular cell. This study defines a cornerstone for the microbial production of lactate esters as green solvents from 
renewable resources with novel industrial applications.
Keywords: Ester, Lactate ester, Ethyl lactate, Isobutyl lactate, Acetate ester, Alcohol acyltransferase, Green solvent, 
Modular cell, Escherichia coli
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Background
Solvents are widely used as primary components of 
cleaning agents, adhesives, and coatings and in assist-
ing mass and heat transfer, separation and purification 
of chemical processes [1]. However, these solvents are 
volatile organic compounds (VOCs) that contribute 
to ozone depletion and photochemical smog via free 
radical air oxidation and hence cause many public 
health problems such as eye irritation, headache, aller-
gic skin reaction, and cancer [1, 2]. Thus, recent inter-
est in the use of alternative green solvents is increasing 
to  satisfy environmental regulation and compelling 
demand for the eco-friendly solvents derived from 
renewable sources [3, 4].
Lactate esters are platform chemicals that have a broad 
range of industrial applications in flavor, fragrance, and 
pharmaceutical industries [5]. These esters are generally 
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toxicological and environmental profiles. For instance, 
ethyl lactate is 100% biodegradable, non-carcinogenic, 
non-corrosive, low volatile, and unhazardous to human 
health and the environment [6]. Due to the unique ben-
eficial properties of ethyl lactate, it has been approved as 
a Significant New Alternatives Policy (SNAP) solvent by 
the U.S. Environmental Protection Agency (EPA) and as 
food additives by the U.S. Food and Drug Administra-
tion (FDA) [6]. Recent technical and economic analysis 
conducted by the National Renewable Energy Laboratory 
(NREL) considers ethyl lactate to be one of the top 12 
bioproducts [7].
In industrial chemical processes, lactate esters are 
currently produced by esterification of lactic acid with 
alcohols using homogenous catalysts (e.g., sulfuric acid, 
hydrogen chloride, and/or phosphoric acid) under high 
temperature reaction conditions [8]. However, use of 
strong acids as catalysts causes corrosive problems and 
often requires more costly equipment for process opera-
tion and safety. Furthermore, the esterification reactions 
are thermodynamically unfavorable (ΔG = + 5 kcal/mol) 
in aqueous solutions and often encounter significant 
challenge due to self-polymerization of lactate [9]. Alter-
natively, microbial catalysts can be harnessed to produce 
these esters from renewable and sustainable feedstocks in 
a thermodynamically favorable reaction (ΔG = − 7.5 kcal/
mol) in an aqueous phase environment at room tempera-
ture and atmospheric pressure [10–16]. This reaction 
uses an alcohol acyltransferase (AAT) to generate an 
ester by condensing an alcohol and an acyl-CoA. AAT 
can catalyze a broad substrate range including (i) linear 
or branched short-to-long chain fatty alcohols [10, 11, 
17], (ii) aromatic alcohols [18], and (iii) terpenols [19–22] 
as well as various fatty acyl-CoAs [11, 13]. To date, while 
microbial biosynthesis of the precursor metabolites for 
lactate esters have been well established such as lactate 
[13, 16, 23–27], lactyl-CoA [28–30], ethanol [31, 32], 
propanol [33], isopropanol [34], butanol [35], isobutanol 
[36], amyl alcohol [37], isoamyl alcohol [38], benzyl alco-
hol [39], 2-phenylethanol [40, 41], and terpenols [19–22], 
the direct microbial biosynthesis of lactate esters from 
fermentable sugars has not yet been demonstrated.
In this work, we aimed to demonstrate the feasibility 
of microbial production of lactate esters as green organic 
solvents from renewable resources. To enable the direct 
microbial biosynthesis of lactate esters from fermentable 
sugars, we first screened for an efficient AAT suitable for 
lactate ester production using a library of five pyruvate-
to-lactate ester modules with divergent AATs. We next 
demonstrated direct fermentative biosynthesis of ethyl 
and isobutyl lactate esters from glucose by co-introduc-
ing a pyruvate-to-lactate ester module and an alcohol 
module (i.e., ethanol and isobutanol) into an engineered 
Escherichia coli modular cell. As a proof-of-study to 
improve ethyl lactate production, we employed a com-
bination of metabolic engineering and synthetic biology 
approaches to dissect the pathway to probe and alleviate 
the potential metabolic bottlenecks.
Results and discussion
In vivo screening of efficient AATs critical for lactate ester 
biosynthesis
The substrate specificity of AATs is critical to produce 
target esters [13]. For example, ATF1 exhibits substrate 
preference for biosynthesis of acyl (C4–C6) acetates 
while SAAT and VAAT prefer biosynthesis of ethyl (C2–
C6) acylates. Even though both SAAT and VAAT are 
derived from the same strawberry genus, they also show 
very distinct substrate preferences; specifically, SAAT 
prefers longer (C4–C6) acyl-CoAs whereas VAAT prefers 
shorter (C2–C4) acyl-CoAs. To date, none of AATs have 
been tested for lactate ester biosynthesis. Thus, to enable 
lactate ester biosynthesis, we began with identification of 
the best AAT candidate. We designed, constructed, and 
characterized a library of five pyruvate-to-lactate ester 
modules (pJW002-006) carrying five divergent AATs 
including ATF1, ATF2, SAAT, VAAT, and AtfA, respec-
tively. AtfA was used as a negative control because it 
prefers long-chain acyl-CoAs (C14–C18) and alcohols 
(C14–C18) [42]. For characterization, 2  g/L of ethanol, 
propanol, butanol, isobutanol, isoamyl alcohol, and ben-
zyl alcohol were added to culture media with 0.5 mM of 
IPTG for pathway induction to evaluate biosynthesis of 
six different lactate esters including ethyl lactate, propyl 
lactate, butyl lactate, isobutyl lactate, isoamyl lactate, and 
benzyl lactate, respectively, in high cell density cultures 
(Fig. 1a).
The results show that most of the strains could produce 
different types of lactate esters with external supply of 
alcohols (Fig. 1b, c). EcJW104 achieved the highest titer 
of lactate esters in all cases, producing 1.59 ± 0.04 mg/L 
of ethyl lactate, 5.46 ± 0.25  mg/L of propyl lactate, 
11.75 ± 0.43  mg/L of butyl lactate, 9.92 ± 0.08  mg/L of 
isobutyl lactate, 24.73 ± 0.58 mg/L of isoamyl lactate, and 
51.59 ± 2.09 mg/L of benzyl lactate in ethanol, propanol, 
butanol, isobutanol, isoamyl alcohol, and benzyl alco-
hol doping, respectively. The lactate ester biosynthesis 
of EcJW104 exhibited different alcohol substrate prefer-
ence in the following order: benzyl alcohol > isoamyl alco-
hol > butanol > isobutanol > propanol > ethanol (Fig.  1b, 
Additional file 1: Table S2).
Due to the presence of endogenous acetyl-CoA, we also 
produced acetate esters in addition to lactate esters (Fig. 1). 
Among the strains, EcJW101 achieved the highest titers of 
acetate esters in all cases, producing 115.52 ± 4.83  mg/L 
of ethyl acetate, 801.62 ± 33.51  mg/L of propyl acetate, 
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Fig. 1 In vivo characterization of various alcohol acyltransferases for biosynthesis of lactate esters. a Biosynthesis pathways of lactate and acetate 
esters with external supply of alcohols. b Ester production of EcJW101, EcJW102, EcJW103, EcJW104, and EcJW105 harboring ATF1, ATF2, SAAT , VAAT ,  
and atfA, respectively in high cell density cultures with various alcohol doping. Each error bar represents 1 standard deviation (s.d., n = 3). Symbols: 
n.d. not detected, n.s. not significant, *p < 0.073, and **p < 0.013 (Student’s t‑test). c The library of esters produced. Green check marks indicate the 
esters produced in this study while red star marks indicate the esters produced for first time in engineered strains
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1017.90 ± 20.21 mg/L of butyl acetate, 1210.40 ± 24.83 mg/L 
of isobutyl acetate, 692.73 ± 7.65 mg/L of isoamyl acetate, 
and 1177.98 ± 45.72  mg/L of benzyl acetate in ethanol, 
propanol, butanol, isobutanol, isoamyl alcohol, and ben-
zyl alcohol doping, respectively. EcJW101 showed dif-
ferent alcohol substrate preference for the acetate ester 
biosynthesis in the following order: isobutanol > benzyl 
alcohol > butanol > propanol > isoamyl alcohol > ethanol 
(Additional file 1: Table S2).
Taken altogether, VAAT and ATF1 are the most suitable 
AATs for biosynthesis of lactate esters and acetate esters, 
respectively. Among the library of 12 esters (Fig.  1c), 
seven of these esters, including ethyl lactate, propyl lac-
tate, butyl lactate, isobutyl lactate, isoamyl lactate, benzyl 
lactate, and benzyl acetate, were demonstrated for in vivo 
production in microbes for the first time. EcJW104 that 
harbors the pyruvate-to-lactate module with VAAT could 
produce 6 out of 6 target lactate esters including ethyl, 
propyl, butyl, isobutyl, isoamyl, and benzyl lactate. Since 
EcJW104 achieved the highest titer of lactate esters in 
all cases, it was selected for establishing the biosynthesis 
pathway of lactate esters from glucose.
Establishing the lactate ester biosynthesis pathways
We next demonstrated direct fermentative production of 
lactate esters from glucose using the best VAAT candi-
date. We focused on the biosynthesis of ethyl and isobu-
tyl lactate esters. We designed the biosynthesis pathways 
for ethyl and isobutyl lactate by combining the pyru-
vate-to-lactate ester module (pJW005) with the ethanol 
(pCT24) and isobutanol (pCT13) modules, respectively. 
By co-transforming pJW005/pCT24 and pJW005/pCT13 
into the modular cell EcDL002, we generated the produc-
tion strains, EcJW201 and EcJW202, for evaluating direct 
conversion of glucose to ethyl and isobutyl lactate esters, 
respectively.
We characterized EcJW201 and EcJW202 together 
with the parent strain, EcDL002, as a negative control 
in high cell density cultures. The results show EcJW201 
and EcJW202 produced ethyl (Fig.  2a) and isobutyl 
(Fig.  2b) lactate from glucose, respectively, while the 
negative control strain EcDL002 could not. Consistently, 
the expressions of metabolic enzymes of the ethyl and 
isobutyl lactate pathways were confirmed in EcJW201 
and EcJW202, respectively, by SDS-PAGE analysis 
(Additional file 2: Figure S1). During 24 h fermentation, 
EcJW201 produced 2.24 ± 0.28  mg/L of ethyl lactate 
with a specific productivity of 0.04 ± 0.00  mg/gDCW/h 
while EcJW202 produced 0.26 ± 0.01  mg/L of isobutyl 
lactate with a specific productivity of 0.01 ± 0.00  mg/
gDCW/h. In addition to ethyl or isobutyl lactate bio-
synthesis, EcJW201 also produced 92.25 ± 9.20  mg/L of 
ethyl acetate while EcJW202 generated 1.36 ± 0.74 mg/L 
of ethyl acetate and 0.34 ± 0.07  mg/L of isobutyl ace-
tate (Additional file 1: Table S3A). Taken altogether, the 
direct microbial synthesis of lactate esters from ferment-
able sugar was successfully demonstrated. Since the lac-
tate ester production was low, the next logical step was 
to identify and alleviate the key pathway bottlenecks for 
enhanced lactate ester biosynthesis. As proof-of-princi-
ple, we focused on optimization of the ethyl lactate pro-
duction as presented in the subsequent sections.
Identifying and alleviating key bottlenecks of the ethyl 
lactate biosynthesis pathway
Evaluating the biosynthesis of ethyl lactate in pH‑controlled 
fermentation as a basis to identify potential pathway 
bottlenecks
In an attempt to identify the key bottlenecks of the 
ethyl lactate biosynthesis pathway, we characterized 
EcJW201 in pH-controlled bioreactors. The results 
show that EcJW201 produced 9.17 ± 0.12 mg/L of ethyl 
lactate with a specific productivity of 0.15 ± 0.02  mg/
gDCW/h and a yield of 0.19 ± 0.00  mg/g glucose 
(Fig.  2c, Additional file  1: Table  S3B) in 18  h. Under 
pH-controlled fermentation, EcJW201 achieved 4.09-
fold (from 2.24 ± 0.28 to 9.17 ± 0.12  mg/L), 3.75-fold 
(from 0.04 ± 0.00 to 0.15 ± 0.02  mg/gDCW/h), and 
19-fold (from 0.01 ± 0.00 to 0.19 ± 0.00  mg/g glu-
cose) improvement in titer, specific productivity, and 
yield, respectively, as compared to the strain perfor-
mance in the high cell density culture. It is interesting 
to observe that ethyl acetate was first produced then 
consumed after 10 h, which is likely due to the endog-
enous esterase of E. coli as observed in a recent study 
[15]. Different from ethyl acetate, we did not observe 
ethyl lactate degradation during fermentation, espe-
cially after glucose was depleted. Even though the 
strain performance in pH-controlled bioreactors was 
enhanced by increased supply of precursor metabo-
lites (19.35 ± 0.29 g/L of lactate and 10.31 ± 0.41 g/L of 
ethanol, Additional file 1: Table S3B) from higher con-
centration of carbon source, the titer of ethyl lactate 
did not increase during the fermentation. This result 
suggests that (i) rate-limiting conversion of lactate into 
lactyl-CoA by Pct and/or condensation of lactyl-CoA 
with an ethanol by VAAT and/or (ii) toxicity of ethyl 
lactate on E. coli health might have limited lactate 
ester biosynthesis. Therefore, to enhance ethyl lactate 
production, it is important to elucidate and alleviate 
these identified potential bottlenecks.
Ethyl lactate exhibited minimal toxicity on cell growth 
among lactate esters
To determine whether lactate esters inhibited cell growth 
and hence contributed to low lactate ester production, 
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we cultured the parent strain, EcDL002, in a microplate 
reader with or without supply of various concentrations 
of lactate esters including ethyl, propyl, butyl, isobutyl, 
isoamyl, or benzyl lactate. The results show that ethyl 
lactate was the least toxic among the six lactate esters 
characterized where the growth rate (0.47 ± 0.04  L/h) 
and cell titer  (OD600 = 0.42 ± 0.03) decreased by 6% and 
10%, respectively, upon cell exposure to 5 g/L ethyl lac-
tate. On the other hand, isoamyl lactate was the most 
toxic among the lactate esters, where cell exposure to 
only 0.5 g/L ester resulted in 18% and 15% reduction in 
the growth rate (0.41 ± 0.02 L/h) and  OD600 (0.40 ± 0.03), 
respectively (Additional file  2: Figure S2A). The toxic-
ity of lactate esters can be ranked in the following order: 
isoamyl lactate > benzyl lactate > butyl lactate > isobutyl 
lactate > propyl lactate > ethyl lactate. There existed a pos-
itive correlation between the logP values of lactate esters 
and their degrees of toxicity (Additional file  2: Figure 
Fig. 2 Design, construction, and validation of the lactate ester biosynthesis pathways in E. coli. a Engineered biosynthesis pathway of ethyl lactate 
from glucose and its production in high cell density culture of EcJW201. b Engineered biosynthesis pathway of isobutyl lactate from glucose and 
its production in high cell density culture of EcJW202. In a and b, all of the strains were induced at 0 h with 0.5 mM IPTG. Each error bar represents 
1 s.d. (n = 3). c Production of ethyl lactate from glucose in pH‑controlled batch fermentation of EcJW201. The strain was induced at 6 h with 0.5 mM 
IPTG. Each error bar represents 1 s.d. (n = 2)
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S2B). This result was consistent with literature, illustrat-
ing that increasing toxicity of esters is highly correlated 
with increasing chain length of alcohol moieties that can 
severely disrupt cell membrane [43]. It should be note 
that since E. coli can effectively secrete short-chain esters 
[10], external exposure of cells to lactate esters in our 
experiment design is sufficient to probe the potential tox-
icity caused by endogenous production of these esters. 
Taken altogether, ethyl lactate is the least toxic and was 
not likely the main reason for the low production of ethyl 
lactate observed. It was likely the downstream pathway, 
responsible for conversion of lactate into lactyl-CoA by 
Pct and/or condensation of lactyl-CoA with ethanol by 
VAAT, might have been contributed to the inefficient 
ethyl lactate biosynthesis.
Downstream pathway of  the  lactate ester biosynthesis 
is  the key bottleneck To identify and alleviate the ethyl 
lactate biosynthesis pathway, we re-modularized it with 
two new parts: (i) the upstream module carrying ldhA, 
pdc, and adhB for production of lactate and ethanol from 
sugar and (ii) the downstream module carrying pct and 
VAAT for converting lactate into lactyl-CoA and con-
densing lactyl-CoA and ethanol (Fig. 3a). We controlled 
metabolic fluxes of these modules by manipulating their 
plasmid copy numbers and levels of promoter induction 
with IPTG. By introducing the plasmids pJW007-015 
into EcDL002, we generated the strains EcJW106-108 
and EcJW203-208, respectively (Fig. 3b). To evaluate the 
performance of these constructed strains for ethyl lactate 
production, we characterized them in high cell density 
cultures induced with various concentrations of IPTG 
(0.01, 0.1, and 1.0 mM).
The results show that EcJW204, carrying the upstream 
module with a low copy number plasmid (P15A origin) 
and the downstream module with a high copy number 
plasmid (RSF1030 origin) induced by 0.01 mM of IPTG, 
achieved the highest titer of ethyl lactate. As compared to 
EcJW201, EcJW204 achieved 4.96-fold (an increase from 
2.24 to 11.10 ± 0.58 mg/L), 5.50-fold (from 0.04 ± 0.00 to 
0.22 ± 0.02 mg/gDCW/h), and 54.0-fold (from 0.01 ± 0.00 
to 0.54 ± 0.04  mg/g glucose) improvement in titer, spe-
cific productivity, and yield of ethyl lactate, respectively 
(Fig. 3b, Additional file 1: Table S5). Upon IPTG induc-
tion at 24  h, we observed the reduced cell growth of 
the host strains with use of high concentration of IPTG 
(Fig. 3c, Additional file 1: Table S4), suggesting that they 
suffered from metabolic burden due to overexpression of 
multiple enzymes [44] and also explaining why use of low 
concentration of IPTG can help yield better production 
of ethyl lactate.
Although EcJW204 showed better performance in 
ethyl lactate production than EcJW201, the accumula-
tion of lactate and ethanol was still observed (Fig. 3f, g, 
Additional file  1: Table  S4), indicating the pathway bot-
tleneck remained. In particular, the downstream mod-
ule flux was outcompeted by the upstream module flux 
and hence failed to turn over the precursor metabolites 
quickly enough. This result helps explain why a combina-
tion of the upstream module (for producing lactate and 
ethanol from sugar) with a low copy number plasmid 
and the downstream module (for converting lactate into 
lactyl-CoA and condensing lactyl-CoA and ethanol) with 
a high copy number plasmid outperformed eight other 
combinations. Notably, the best ethyl lactate producer 
EcJW204 achieved the highest lactate and lowest ethanol 
production among the nine characterized strains (Fig. 3f, 
g, Additional file  1: Table  S4), suggesting redistribution 
of the carbon flux from ethanol to lactate likely helped 
improve ethyl lactate production. Thus, we hypothesized 
that redistribution of the carbon source from ethanol to 
lactate would help to improve ethyl lactate production. 
To test this hypothesis, we first examined whether (i) 
downregulation of the ethanol flux of the upstream mod-
ule enabled redistribution of the carbon flow from etha-
nol to lactate and (ii) this redistribution could improve 
ethyl lactate production before proceeding to investigate 
the potential bottleneck of downstream module.
High ethanol synthesis of the upstream module was criti‑
cal for  ethyl lactate biosynthesis due to  low specificity 
and  activity of  AAT To downregulate the ethanol flux 
of the upstream module, we first reconfigured pJW007, 
the upstream module of the best performer EcJW204, 
with a library of two weaker promoters and four weaker 
synthetic RBSs (Fig.  4a, Additional file  2: Figure S3A), 
(See figure on next page.)
Fig. 3 Combinatorial modular pathway optimization for enhanced ethyl lactate biosynthesis by varying plasmid copy number. a Re‑modularization 
of the ethyl lactate biosynthesis pathway. Pyruvate‑to‑lactate ester and ethanol modules were re‑modulated into upstream and downstream 
modules using plasmids with different copy numbers. b Ethyl lactate production, c  OD600, d Consumed glucose, e Acetate, f Lactate, g Ethanol, 
and h Ethyl acetate of EcJW106‑108 and EcJW203‑208 in high cell density cultures induced with various concentrations of IPTG. Green rectangle: 
low copy number plasmid (10); P15A: origin of pACYCDuet‑1; blue rectangle: medium copy number plasmid (40); ColE1: origin of pETDuet‑1; red 
rectangle: high copy number plasmid (100); RSF1030: origin of pRSFDuet‑1;  PT7: T7 promoter;  TT7: T7 terminator. All of the strains were induced at 
0 h with 0.01, 0.1, or 1.0 mM IPTG, respectively. Each error bar represents 1 s.d. (n = 3). Red arrows indicate the selected strain with an optimum 
concentration of IPTG for the further studies
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resulting in four new upstream modules (pJW019-022). 
By introducing each newly constructed upstream mod-
ule into EcDL002 together with the downstream module 
pJW012 used in EcJW204, we next generated the strains 
EcJW209-212 and characterized them in high cell density 
cultures induced with 0.01 mM IPTG.
The results show that while the carbon flux was suc-
cessfully redistributed from ethanol to lactate, resulting 
in 5.97- to 6.92-fold decrease in ethanol production (from 
8.30 ± 0.17 to 1.39 ± 0.10 ~ 1.20 ± 0.01  g/L) and 1.67- to 
2.59-fold increase in lactate production (from 1.06 ± 0.09 
to 1.77 ± 0.37  g/L ~ 2.75 ± 0.09  g/L) (Additional file  1: 
Table  S6A), the ethyl lactate production was reduced 
by 7.99- to 11.81-fold in ethyl lactate production (from 
11.10 ± 0.58 to 1.39 ± 0.40 ~ 0.94 ± 0.22 mg/L) in all four 
characterized strains as compared to that of EcJW204 
(Fig. 4b, Additional file 1: Table S6B). This result suggests 
that a high level of ethanol is critical for VAAT to pro-
duce ethyl lactate.
To support this conclusion, we evaluated the effect 
of external ethanol supply on production of ethyl esters 
in high cell density cultures of EcJW209-212 induced 
with 0.01  mM IPTG. Indeed, with external ethanol sup-
ply, we observed enhanced production of both ethyl lac-
tate and ethyl acetate in EcJW209-212. In specific, with 
addition of 2  g/L of ethanol, the ethyl lactate and ethyl 
acetate production increased by 2.27- to 3.33-fold (from 
1.39 ± 0.40 to 3.15 ± 0.15  mg/L ~ from 0.98 ± 0.15 to 
3.26 ± 0.26 mg/L) and 1.27- to 2.07-fold (from 36.46 ± 3.86 to 
46.22 ± 1.33 mg/L ~ from 21.96 ± 0.84 to 45.40 ± 1.20 mg/L), 
respectively (Additional file  1: Table  S6). Further addi-
tion of ethanol up to 10  g/L improved the ethyl lactate 
and ethyl acetate production by 3.78- to 5.26-fold (from 
1.39 ± 0.40 to 5.26 ± 0.27  mg/L ~ from 0.94 ± 0.15  mg/L to 
4.49 ± 0.41 mg/L) and 4.09- to 6.92-fold (from 36.46 ± 3.86 
to 148.97 ± 3.80  mg/L ~ from 21.96 ± 0.84  mg/L to 
151.87 ± 2.34 mg/L), respectively (Additional file 1: Table S6). 
Interestingly, while the total titer of ethyl esters increased 
with the increasing addition of ethanol (Fig. 5a), the propor-
tion of ethyl lactate in the total ester slightly increased in the 
range of 3.2–7.0% (Fig.  5b), suggesting that VAAT prefers 
acetyl-CoA over lactyl-CoA with ethanol as a co-substrate. 
Notably, we observed a strong linear correlation between 
ethyl esters production and the amount of added etha-
nol (i.e., for ethyl lactate, R2 = 0.85–0.94; for ethyl acetate, 
R2 = 0.99–1.00) (Additional file  2: Figure S4A). The results 
revealed that abundant availability of ethanol is essential to 
achieve high production of ethyl esters, indicating the main 
reason for the improved ethyl lactate production in EcJW204 
was most likely due to the upregulation of downstream mod-
ule with a high copy number plasmid.
AAT was the most rate‑limiting step of the downstream 
module To determine whether Pct for conversion 
of lactate to lactyl-CoA or VAAT for condensation of 
lactyl-CoA and an alcohol was the most rate-limiting 
step of the downstream module, we redesigned and 
constructed nine downstream modules (pJW027-035) 
derived from pJW012 of the best performer EcJW204 
using a combination of three synthetic RBSs for Pct 
expression  (synRBSpct#1-3) and three synthetic RBSs for 
VAAT expression  (synRBSVAAT#1-3) (Fig. 4a, Additional 
file  2: Figure S3B). We introduced each newly con-
structed downstream module into EcDL002 together 
with the original upstream module (pJW007) used in 
EcJW204 to generate EcJW213-221. Then, we charac-
terized the constructed strains in high cell density cul-
tures induced with 0.01 mM IPTG.
The results show that the strains harboring the 
stronger RBSs for VAAT expression achieved the higher 
titers of ethyl lactate and ethyl acetate regardless of the 
RBS strengths for Pct expression (Fig.  4c, Additional 
file  1: Table  S7). There is a strong linear correlation 
Fig. 4 Probing and alleviating the potential metabolic bottlenecks of the upstream or downstream modules of EcJW204 by varying the strength 
of promoters and/or ribosome binding sites. a Design of synthetic operons for the upstream and downstream modules. For the upstream module, 
the T7 promoter in MCS2 and the RBS between T7 promoter in MCS2 and the start codon of pdc were replaced with the combination of  PAY1 or  PAY3 
promoter and 0.3 or 0.03 a.u. RBS. For the downstream module, the RBS between T7 promoter in MCS1 and the start codon of pct gene and the RBS 
between T7 promoter in MCS2 and the start codon of VAAT gene were replaced with the combination of 90, 9000, or 90000 a.u. RBS and 90, 9000, 
or 90000au RBS, respectively. Production of ethyl lactate in high cell density cultures of b EcJW209‑212 and c EcJW213‑221. Green rectangle: low 
copy number plasmid (10); P15A: origin of pACYCDuet‑1; red rectangle: high copy number plasmid (100); RSF1030: origin of pRSFDuet‑1;  PT7: T7 
promoter;  TT7: T7 terminator. All of the strains were induced at 0 h with 0.01 mM IPTG. Each error bar represents 1 s.d. (n = 3)
(See figure on previous page.)
(See figure on next page.)
Fig. 5 a Total esters and b Composition of total esters produced in high cell density cultures of EcJW209‑212 with or without addition of ethanol. 
c Ethyl lactate production of EcJW109‑117 with addition of 2 g/L of lactate and ethanol. Red rectangle: high copy number plasmid (100); RSF1030: 
origin of pRSFDuet‑1;  PT7: T7 promoter;  TT7: T7 terminator. All of the strains were induced at 0 h with 0.01 mM IPTG. Each error bar represents 1 s.d. 
(n = 3)
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between ethyl ester production and the strength of RBS 
for VAAT expression (Additional file  2: Figure S4B). 
To further validate these results without the influence 
of the upstream module, we additionally constructed 
the strains EcJW109-117 by introducing nine individ-
ual downstream modules (pJW027-035) into EcDL002 
and then characterized these strains in high cell density 
cultures with addition of 2 g/L of lactate, 2 g/L of etha-
nol, and 0.01 mM of IPTG. We could observe the same 
strong linear correlation between ethyl ester produc-
tion and high VAAT expression without the upstream 
module (Fig. 5c).
Taken altogether, these results suggest that VAAT not 
Pct was the most rate-limiting step of the downstream 
module of the ethyl lactate biosynthesis pathway. In spe-
cific, a combination of low affinity toward lactyl-CoA and 
ethanol of VAAT contributed to low ethyl lactate biosyn-
thesis. Further studies on discovery of novel AATs, exhib-
iting high activity toward lactyl-CoA and alcohols but not 
acetyl-CoA, together with rational protein engineering of 
these enzymes would be warranted for improving lactate 
ester production.
In principle, the lactate ester platform can be con-
trolled to produce enantiomers with broad industrial 
applications. Since the endogenous E. coli d-lactate 
dehydrogenase (LdhA) was overexpressed in the ldhA-
deficient modular cell of our study, it is anticipated that 
d-(−)-lactate and the associated d-(−)-lactate esters 
were mainly produced. To date, production of optically 
pure d-(−)- [23] and l-(+)-form [26] of lactate from glu-
cose in E. coli [25] has been well established. In addition, 
pct from C. propionicum [28] and Megasphaera elsdenii 
[29, 30] has been used for converting d-(−)-lactate into 
d-(−)-lactyl-CoA in polylactic acid (PLA) production in 
E. coli and their catalytic activity toward l-(+)-lactate 
has also been demonstrated [45, 46]. Thus, by combining 
stereospecific Ldh and Pct enzymes together with AATs, 
it is highly feasible to extend our lactate ester platform 
for microbial production of stereospecific lactate esters 
from renewable resources.
Conclusions
In this study, we have successfully developed a microbial 
lactate ester production platform and demonstrated for 
the first time the microbial biosynthesis of lactate esters 
directly from fermentable sugars in an E. coli modu-
lar cell. This study defines a cornerstone for the micro-
bial production of lactate esters as green solvents from 
renewable resources with novel industrial applications.
Methods
Strain construction
The list of strains used in this study is presented in 
Table 1. For molecular cloning, E. coli TOP10 strain was 
used. To generate the lactate ester production strains, 
the modules, including (i) the pyruvate-to-lactate ester 
modules (pJW002-006), (ii) the upstream and/or down-
stream modules (pJW007-pJW028), and (iii) the alcohol 
modules (pCT24 or pCT13), were transformed into the 
engineered modular E. coli chassis cell, EcDL002 [10] via 
electroporation [47].
Plasmid construction
The list of plasmids and primers used in this study are 
presented in Tables  2 and 3, respectively. Pathway con-
struction includes pyruvate-to-lactate ester modules and 
a library of upstream and downstream modules with 
various plasmid copy numbers, promoters, and ribosome 
binding sites (RBSs).
Construction of pyruvate‑to‑lactate ester modules
A library of pyruvate-to-lactate ester modules with five 
divergent AATs was constructed to screen for an effi-
cient AAT for production of lactate esters via two rounds 
of cloning. First, the pyruvate-to-lactyl-CoA module 
(pJW001) was constructed by assembling three DNA 
fragments: (i) the ldhA gene, encoding d-lactate dehy-
drogenase, amplified from E. coli MG1655 genomic DNA 
using the primer pair DL_0032/DL_0033, (ii) the pct 
gene, encoding propionate CoA-transferase, amplified 
from Clostridium propionicum genomic DNA using the 
primer pair DL_0034/DL_0035, and (iii) the backbone 
amplified from pETite* using the primer pair DL_0001/
DL_0002 [48]. Then, the pyruvate-to-lactate ester mod-
ules (pJW002-006) were constructed by assembling three 
DNA fragments: (i) the pyruvate-to-lactyl-CoA module 
amplified from pJW001 using the primer pair DL_0032/
DL_0014, (ii) the ATF1 gene amplified from pDL004 
for pJW002, the ATF2 gene amplified from pDL005 
for pJW003, the SAAT gene amplified from pDL001 
for pJW004, the VAAT gene amplified from pDL006 
for pJW005, or the atfA gene amplified from pCT16 
for pJW006, using the primer pair DL_0015/DL_0016, 
and (iii) the backbone amplified from pETite* using the 
primer pair DL_0013/DL_0002. The genes ATF1 and 
ATF2 are originated from Saccharomyces cerevisiae [49], 
whereas the genes SAAT , VAAT , and atfA are derived 
from Fragaria ananassa [50], F. vesca [51], and Acineto‑
bacter sp. ADP1 [52], respectively.
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Construction of a library of upstream and downstream 
modules with various plasmid copy numbers
A library of upstream and downstream modules was con-
structed to improve ethyl lactate biosynthesis through a 
combinatorial pathway optimization strategy using three 
different plasmids: (i) pACYCDuet-1 (P15A origin of 
replication), (ii) pETDuet-1 (ColE1 origin), and (iii) pRS-
FDuet-1 (RSF1030 origin), having the plasmid copy num-
bers of 10, 40, and 100, respectively [53].
Table 1 A list of strains used in this study
Strains Genotypes Sources
E. coli TOP10 F‑mcrA Δ(mrr‑hsdRMS‑mcrBC) Φ80lacZΔM15 ΔlacX74 recA1  
araD139 Δ(ara leu) 7697 galU galK rpsL (StrR) endA1 nupG
Invitrogen
E. coli MG1655 F− λ− ATCC 47076
Clostridium propionicum Wildtype ATCC 25522
EcDL002 TCS083 (λDE3) ΔfadE [10]
EcJW101 EcDL002/pJW002;  ampR This study
EcJW102 EcDL002/pJW003;  ampR This study
EcJW103 EcDL002/pJW004;  ampR This study
EcJW104 EcDL002/pJW005;  ampR This study
EcJW105 EcDL002/pJW006;  ampR This study
EcJW201 EcDL002/pJW005 pCT24;  ampR  kanR This study
EcJW202 EcDL002/pJW005 pCT13;  ampR  kanR This study
EcJW106 EcDL002/pJW013;  cmR This study
EcJW203 EcDL002/pJW007 pJW011;  cmR  ampR This study
EcJW204 EcDL002/pJW007 pJW012;  cmR  kanR This study
EcJW205 EcDL002/pJW008 pJW010;  cmR  ampR This study
EcJW107 EcDL002/pJW014;  ampR This study
EcJW206 EcDL002/pJW008 pJW012;  ampR  kanR This study
EcJW207 EcDL002/pJW009 pJW010;  cmR  kanR This study
EcJW208 EcDL002/pJW009 pJW011;  ampR  kanR This study
EcJW108 EcDL002/pJW015;  kanR This study
EcJW209 EcDL002/pJW019 pJW012;  cmR  kanR This study
EcJW210 EcDL002/pJW020 pJW012;  cmR  kanR This study
EcJW211 EcDL002/pJW021 pJW012;  cmR  kanR This study
EcJW212 EcDL002/pJW022 pJW012;  cmR  kanR This study
EcJW213 EcDL002/pJW007 pJW027;  cmR  kanR This study
EcJW214 EcDL002/pJW007 pJW028;  cmR  kanR This study
EcJW215 EcDL002/pJW007 pJW029;  cmR  kanR This study
EcJW216 EcDL002/pJW007 pJW030;  cmR  kanR This study
EcJW217 EcDL002/pJW007 pJW031;  cmR  kanR This study
EcJW218 EcDL002/pJW007 pJW032;  cmR  kanR This study
EcJW219 EcDL002/pJW007 pJW033;  cmR  kanR This study
EcJW220 EcDL002/pJW007 pJW034;  cmR  kanR This study
EcJW221 EcDL002/pJW007 pJW035;  cmR  kanR This study
EcJW109 EcDL002/pJW027;  kanR This study
EcJW110 EcDL002/pJW028;  kanR This study
EcJW111 EcDL002/pJW029;  kanR This study
EcJW112 EcDL002/pJW030;  kanR This study
EcJW113 EcDL002/pJW031;  kanR This study
EcJW114 EcDL002/pJW032;  kanR This study
EcJW115 EcDL002/pJW033;  kanR This study
EcJW116 EcDL002/pJW034;  kanR This study
EcJW117 EcDL002/pJW035;  kanR This study
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Table 2 A list of plasmids used in this study
Plasmids Genotypes Sources
pACYCDuet‑1 Two sets of MCS,  T7 promoter, P15A ori;  cm
R Novagen
pETDuet‑1 Two sets of MCS,  T7 promoter, ColE1 ori;  amp
R Novagen
pRSFDuet‑1 Two sets of MCS,  T7 promoter, RSF1030 ori;  kan
R Novagen
pETite* T7 promoter, pBR322 ori;  kan
R [10]
pCT24 pETite*  PT7::pdc::adhB::TT7;  kan
R [10]
pCT13 pCOLA  PT7::alsS::ilvC::ilvD‑PT7::kivd::adhE::TT7;  kan
R [57]
pDL004 pETite* ATF1;  kanR [13]
pDL005 pETite* ATF2;  kanR [13]
pDL001 pETite* SAAT ;  kanR [13]
pDL006 pETite* VAAT ;  kanR [13]
pCT16 pETite* atfA;  kanR [58]
pJW001 pETite*  PT7::ldhA::pct::TT7;  amp
R This study
pJW002 pJW001  PT7::ldhA::pct‑PT7::ATF1::TT7;  amp
R This study
pJW003 pJW001  PT7::ldhA::pct‑PT7::ATF2::TT7;  amp
R This study
pJW004 pJW001  PT7::ldhA::pct‑PT7::SAAT ::TT7;  amp
R This study
pJW005 pJW001  PT7::ldhA::pct‑PT7::VAAT ::TT7;  amp
R This study
pJW006 pJW001  PT7::ldhA::pct‑PT7::atfA::TT7;  amp
R This study
pJW007 pACYCDuet‑1  PT7::ldhA::pdc::adhB::TT7;  cm
R This study
pJW008 pETDuet‑1  PT7::ldhA::pdc::adhB::TT7;  amp
R This study
pJW009 pRSFDuet‑1  PT7::ldhA::pdc::adhB::TT7;  kan
R This study
pJW010 pACYCDuet‑1  PT7::pct::VAAT ::TT7;  cm
R This study
pJW011 pETDuet‑1  PT7::pct::VAAT ::TT7;  amp
R This study
pJW012 pRSFDuet‑1  PT7::pct::VAAT ::TT7;  kan
R This study
pJW013 pACYCDuet‑1  PT7::ldhA::pdc::adhB‑PT7::pct::VAAT ::TT7;  cm
R This study
pJW014 pETDuet‑1  PT7::ldhA::pdc::adhB‑PT7::pct::VAAT ::TT7;  amp
R This study
pJW015 pRSFDuet‑1  PT7::ldhA::pdc::adhB‑PT7::pct::VAAT ::TT7;  kan
R This study
pJW016 pACYCDuet‑1  PT7::ldhA::TT7‑PT7::TT7;  cm
R This study
pJW017 pACYCDuet‑1  PT7::ldhA::TT7‑PAY1::TT7;  cm
R This study
pJW018 pACYCDuet‑1  PT7::ldhA::TT7‑PAY3::TT7;  cm
R This study
pJW019 pACYCDuet‑1  PT7::ldhA::TT7‑PAY1::synRBSpdc#1::pdc::adhB::TT7;  cm
R This study
pJW020 pACYCDuet‑1  PT7::ldhA::TT7‑PAY1::synRBSpdc#2::pdc::adhB::TT7;  cm
R This study
pJW021 pACYCDuet‑1  PT7::ldhA::TT7‑PAY3::synRBSpdc#3::pdc::adhB::TT7;  cm
R This study
pJW022 pACYCDuet‑1  PT7::ldhA::TT7‑PAY3::synRBSpdc#4::pdc::adhB::TT7;  cm
R This study
pJW023 pRSFDuet‑1  PT7::pct::TT7‑PT7::TT7;  kan
R This study
pJW024 pRSFDuet‑1  PT7::synRBSpct#1::pct::TT7‑PT7::TT7;  kan
R This study
pJW025 pRSFDuet‑1  PT7::synRBSpct#2::pct::TT7‑PT7::TT7;  kan
R This study
pJW026 pRSFDuet‑1  PT7::synRBSpct#3::pct::TT7‑PT7::TT7;  kan
R This study
pJW027 pRSFDuet‑1  PT7::synRBSpct#1::pct::TT7‑PT7::synRBSVAAT#1::VAAT ::TT7;  kan
R This study
pJW028 pRSFDuet‑1  PT7::synRBSpct#1::pct::TT7‑PT7::synRBSVAAT#2::VAAT ::TT7;  kan
R This study
pJW029 pRSFDuet‑1  PT7::synRBSpct#1::pct::TT7‑PT7::synRBSVAAT#3::VAAT ::TT7;  kan
R This study
pJW030 pRSFDuet‑1  PT7::synRBSpct#2::pct::TT7‑PT7::synRBSVAAT#1::VAAT ::TT7;  kan
R This study
pJW031 pRSFDuet‑1  PT7::synRBSpct#2::pct::TT7‑PT7::synRBSVAAT#2::VAAT ::TT7;  kan
R This study
pJW032 pRSFDuet‑1  PT7::synRBSpct#2::pct::TT7‑PT7::synRBSVAAT#3::VAAT ::TT7;  kan
R This study
pJW033 pRSFDuet‑1  PT7::synRBSpct#3::pct::TT7‑PT7::synRBSVAAT#1::VAAT ::TT7;  kan
R This study
pJW034 pRSFDuet‑1  PT7::synRBSpct#3::pct::TT7‑PT7::synRBSVAAT#2::VAAT ::TT7;  kan
R This study
pJW035 pRSFDuet‑1  PT7::synRBSpct#3::pct::TT7‑PT7::synRBSVAAT#3::VAAT ::TT7;  kan
R This study
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Table 3 A list of primers used in this study
Primers Sequences (5′➝3′)
Pyruvate‑to‑lactyl‑CoA module
 DL_0001 CAT CAT CAC CAC CAT CAC TAA 
 DL_0002 ATG TAT ATC TCC TTC TTA TAG TTA AAC 
 DL_0032 TAG AAA TAA TTT TGT TTA ACT ATA AGA AGG AGA TAT ACA TAT GAA ACT CGC CGT TTA TAG 
 DL_0033 GGG AAC CTT TCT CAT TAT ATC TCC TTT TAA ACC AGT TCG TTC GGGC 
 DL_0034 ACG AAC TGG TTT AAA AGG AGA TAT AAT GAG AAA GGT TCC CAT TAT 
 DL_0035 GCC GCT CTA TTA GTG ATG GTG GTG ATG ATG TCA GGA CTT CAT TTC CTT CAG 
Pyruvate‑to‑lactate ester module
 DL_0013 GAG CCT CAG ACT CCA GCG TA
 DL_0014 ATA TCA AGC TTG AAT TCG TTA CCC GG
 DL_0015 GGA GGA ACT ATA TCC GGG TAA CGA ATT CAA GCT TGA TAT TAA TAC GAC TCA CTA TAGGG 
 DL_0016 GTC CAG TTA CGC TGG AGT CTG AGG CTC 
Upstream module
 JW_0001 GGG CAG CAG CCA TCA CCA TCA TCA CCA CAG CCA GGA TCC ATG AAA CTC GCC GTT TAT AGC 
 JW_0002 CTA AAT AGG TAC CGA CAG TAT AAC TCA TTA TAT CTC CTT TTA AAC CAG TTC GTT CGGGC 
 JW_0003 CGA AAC CTG CCC GAA CGA ACT GGT TTA AAA GGA GAT ATA ATG AGT TAT ACT GTC GGT ACC 
 JW_0004 CGC AAG CTT GTC GAC CTG CAG GCG CGC CGA GCT CGA ATT CTT AGA AAG CGC TCA GGAAG 
 JW_0005 GGA TCC TGG CTG TGG TGA TGA 
 JW_0006 GAA TTC GAG CTC GGC GCG 
Downstream module
 JW_0007 GTA TAT TAG TTA AGT ATA AGA AGG AGA TAT ACA TAT GAT GAG AAA GGT TCC CAT TAT TAC 
 JW_0008 GAA ATT ATA CTG ACC TCA ATT TTC TCC ATT ATA TCT CCT TTC AGG ACT TCA TTT CCTTC 
 JW_0009 AAT GGG TCT GAA GGA AAT GAA GTC CTG AAA GGA GAT ATA ATG GAG AAA ATT GAG GTCAG 
 JW_0010 CAA ATT TCG CAG CAG CGG TTT CTT TAC CAG ACT CGA GTC AAT ATC TTG AAA TTA GCG TCT 
 JW_0011 CAT ATG TAT ATC TCC TTC TTA TAC TTA ACT 
 JW_0012 CTC GAG TCT GGT AAA GAA AC
Synthetic operons for upstream module
 JW_0013 GGG AAT TGT GAG CGG ATA ACA ATT CCC CAA GGA GAT ATA ATG AAA CTC GCC GTT TAT AGC 
 JW_0014 TTA TGC TAG TTA TTG CTC AGC GGT GGC GGC CGC TCT ATT ATT AAA CCA GTT CGT TCGG 
 JW_0015 TCT GGA AAA AGG CGA AAC CTG CCC GAA CGA ACT GGT TTA ATA ATA GAG CGG CCG C
 JW_0016 GAT TAT GCG GCC GTG TAC AAT ACG ATT ACT TTC TGT TCG ATT TCT ACC GAA GAA AGGC 
 JW_0017 CAT TAT ATC TCC TTG GGG AAT TGT TAT CCG C
 JW_0018 TCG AAC AGA AAG TAA TCG TATTG 
 JW_0019 AAA TTT GAC GGC TAG CTC AGT CCT AGG TAC AGT GCT AGC ATG AGT TAT ACT GTC GGT ACC 
 JW_0020 GCG TTC AAA TTT CGC AGC AGC GGT TTC TTT ACC AGA CTC GAG TTA GAA AGC GCT CAG GAA 
 JW_0021 AAA TCT GAC AGC TAG CTC AGT CCT AGG TAT AAT GCT AGC ATG AGT TAT ACT GTC GGT ACC 
 JW_0022 CAT GCT AGC ACT GTA CCT AGG ACT GAG CTA GCC GTC AAA TTT CGA TTA TGC GGC C
 JW_0023 CAT GCT AGC ATT ATA CCT AGG ACT GAG CTA GCT GTC AGA TTT CGA TTA TGC GGC C
 JW_0024 TAC AGT GCT AGC AGC TTA GCG ACA ACC CTA GGC GCT CGC ATG AGT TAT ACT GTC GGT ACC 
 JW_0025 GTA TAA TGC TAG CTT AGC AGT ACC AGG ACG TAC CGG AGT ATG AGT TAT ACT GTC GGT ACC 
 JW_0026 TAG GTA CAG TGC TAG CAC TAG GCC TAG CGA TTC CGC TAA ATG AGT TAT ACT GTC GGT ACC 
 JW_0027 TAT AAT GCT AGC AGT TTA CCT AGG GCA ATA GCG TAC CGA ATG AGT TAT ACT GTC GGT ACC 
 JW_0028 CAT GCG AGC GCC TAG GGT TGT CGC TAA GCT GCT AGC ACT GTA CCT AGG 
 JW_0029 CAT TTA GCG GAA TCG CTA GGC CTA GTG CTA GCA CTG TAC CTA GG
 JW_0030 CAT ACT CCG GTA CGT CCT GGT ACT GCT AAG CTA GCA TTA TAC CTAGG 
 JW_0031 CAT TCG GTA CGC TAT TGC CCT AGG TAA ACT GCT AGC ATT ATA CCT AGG 
Synthetic operons for downstream module
 JW_0032 TTA TGC TAG TTA TTG CTC AGC GGT GGC GGC CGC TCT ATT ATC AGG ACT TCA TTT CCT TCA 
 JW_0033 TGC AGA AGG CTT AAT GGG TCT GAA GGA AAT GAA GTC CTG ATA ATA GAG CGG CCG C
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The upstream modules (pJW007-009) were constructed 
by assembling three DNA fragments: (i) the ldhA gene 
amplified from pJW001 using the primer pair JW_0001/
JW_0002, (ii) the ethanol module containing pdc and 
adhB genes amplified from pCT24 using the primer 
pair JW_0003/JW_0004, and (iii) the backbone ampli-
fied from pACYCDuet-1 for pJW007, from pETDuet-1 
for pJW008, or from pRSFDuet-1 for pJW009 using the 
primer pair JW_0005/JW_0006.
The downstream modules (pJW010-012) were con-
structed by assembling three DNA fragments: (i) the 
pct gene amplified from pJW001 using the primer pair 
JW_0007/JW_0008, (ii) the VAAT gene amplified from 
pJW005 using the primer pair JW_0009/JW_0010, and 
(iii) the backbone amplified from pACYCDuet-1 for 
pJW010, pETDuet-1 for pJW011, or pRSFDuet-1 for 
pJW012 using the primer pair JW_0011/JW_0012.
The combined upstream and downstream modules 
(pJW013-015) were constructed by assembling two 
DNA fragments: (i) the upstream module amplified from 
pJW007 using the primer pair JW_0001/JW_0004 and (ii) 
the backbone containing the downstream module ampli-
fied from pJW010 for pJW013, pJW011 for pJW014, or 
pJW012 for pJW015 using the primer pair JW_0005/
JW_0006.
Construction of a library of upstream and downstream 
modules with various promoters and RBSs
For tighter regulation of biosynthetic pathway of ethyl 
lactate, we constructed the upstream and downstream 
modules with tunable promoters and RBSs.
The upstream modules (pJW019-022) were constructed 
via three rounds of cloning. First, the T7 terminator  (TT7) 
was added between the multiple cloning site 1 (MCS1) 
and MCS2 of the pACYCDuet-1 backbone to create 
the first intermediate plasmid, pJW016, by assembling 
three DNA fragments: (i) the ldhA gene amplified from 
pJW001 using the primer pair JW_0013/JW_0014, (ii) 
the linker containing  TT7 terminator amplified from 
pETite* using the primer pair JW_0015/JW_0016, and 
(iii) the backbone amplified from pACYCDuet-1 using 
the primer pair JW_0017/JW_0018. Next, the original T7 
promoter  (PT7) in MCS2 of pJW016 was replaced with 
the  PAY1 (BBa_J23100) promoter and  PAY3 (BBaJ23108) 
promoter to generate two second-intermediate plas-
mids, pJW017 and pJW018, respectively, by assembling 
two DNA fragments: (i) the ethanol module amplified 
from pCT24 under the  PAY1 promoter for pJW017 or  PAY3 
promoter for pJW018 using the primer pair JW_0019/
JW_0020 or JW_0021/JW_0020, respectively, and (ii) the 
backbone amplified from pJW016 using the primer pair 
JW_0022/JW_0012 or JW_0023/JW_0012, respectively. 
Last, the final four synthetic operons (pJW019-022) were 
constructed by assembling two DNA fragments: (i) the 
ethanol module amplified from pCT24 with the synthetic 
RBS sequences with predicted translation initiation rates 
of 0.33  a.u. for pJW019 and pJW021 and 0.03  a.u. for 
pJW020 and pJW022 using the primer pairs JW_0024/
JW_0020, JW_0025/JW_0020, JW_0026/JW_0020, 
and JW_0027/JW_0020, respectively, and (ii) the back-
bone amplified from pJW017 for pJW019, pJW017 for 
pJW020, pJW018 for pJW021, and pJW018 for pJW022 
using the primer pairs JW_0028/JW_0012, JW_0029/
JW_0012, JW_0030/JW_0012, and JW_0031/JW_0012, 
respectively. The  PAY1 and  PAY3 promoter sequences 
were obtained from the iGEM Anderson promoter 
Table 3 (continued)
Primers Sequences (5′➝3′)
 JW_0034 GAT TAT GCG GCC GTG TAC AAT ACG ATT ACT TTC TGT TCG ATT TCT ACC GAA GAA AGGC 
 JW_0035 GAT ATA GCT CGA ACG CGG AAA GAG ATG AGA AAG GTT CCC ATT ATTAC 
 JW_0036 TCA GGA CTT CAT TTC CTT CA
 JW_0037 GCA ACC TAT TTT AAT CCA AGG AAG ATC TAA TGA GAA AGG TTC CCA TTA TTAC 
 JW_0038 GCA ATA ACA ACT AGG AGA GAC GAC ATG AGA AAG GTT CCC ATT ATTAC 
 JW_0039 TAA TGG GAA CCT TTC TCA TCT CTT TCC GCG TTC GAG CTA TAT CGG GGA ATT GTT ATC CGC 
 JW_0040 TGC AGA AGG CTT AATGG 
 JW_0041 GGA ACC TTT CTC ATT AGA TCT TCC TTG GAT TAA AAT AGG TTG CGG GGA ATT GTT ATC CGC 
 JW_0042 TAA TGG GAA CCT TTC TCA TGT CGT CTC TCC TAG TTG TTA TTG CGG GGA ATT GTT ATC CGC 
 JW_0043 TAA CCA AAA CAC TAA CGC AAG ATG GAG AAA ATT GAG GTC AGT 
 JW_0044 AGG GCA CGA GGA GGA ACC AGT AGA ATG GAG AAA ATT GAG GTC AGT 
 JW_0045 GCA ACC AAC ACA ACG AGG AGG CAT TTA ATG GAG AAA ATT GAG GTC AGT 
 JW_0046 TAC TGA CCT CAA TTT TCT CCA TCT TGC GTT AGT GTT TTG GTT AGG GGA ATT GTT ATC CGC 
 JW_0047 CTC AAT TTT CTC CAT TCT ACT GGT TCC TCC TCG TGC CCT GGG GAA TTG TTA TCC GC
 JW_0048 CTC AAT TTT CTC CAT TAA ATG CCT CCT CGT TGT GTT GGT TGC GGG GAA TTG TTA TCCGC 
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library (http://parts .igem.org/Promo ters/Catal og/Ander 
son) and the strength of promoters were assigned as 
 PAY3 = 0.5 × PAY1. The RBS Calculator v2.0 [54, 55] was 
used to generate four synthetic RBS sequences with 
predicted translation initiation rates of 0.33 and 0.03 
between the  PAY1 (or  PAY3) promoter and pdc start codon 
(Additional file 2: Figure S3).
The downstream modules (pJW027-035) were con-
structed via three rounds of cloning. First, the  TT7 ter-
minator was added between MCS1 and MCS2 of the 
pRSFDuet-1 backbone to generate the first intermediate 
plasmid, pJW023, by assembling three DNA fragments: 
(i) the pct gene amplified from pJW001 using the primer 
pair JW_0013/JW_0032, (ii) the linker containing  TT7 
terminator from pETite* using the primer pair JW_0033/
JW_0034, and (iii) the backbone from pRSFDuet-1 using 
the primer pair JW_0017/JW_0018. Then, the original 
RBS in MCS1 of pJW023 was replaced with synthetic 
RBSs of various strengths to generate the second-inter-
mediate plasmids, pJW024-026, by assembling two DNA 
fragments: (i) the pct gene amplified from pJW001 with 
the synthetic RBS sequences with predicted translation 
initiation rates at 90, 9000, or 90000  a.u. for pJW024, 
pJW025, or pJW026 using the primer pair JW_0035/
JW_0036, JW_0037/JW_0036, or JW_0038/JW_0036, 
respectively, and (ii) the backbone amplified from 
pJW023 using the primer pair JW_0039/JW_0040 for 
pJW024, JW_0041/JW_0040 for pJW025, or JW_0042/
JW_0040 for pJW026, respectively. Last, the final nine 
downstream modules (pJW027-035) were constructed by 
assembling a combination of two DNA fragments: (i) the 
VAAT gene amplified from pDL006 with the synthetic 
RBS sequences predicted with translation initiation rates 
of 90, 9000, or 90000 a.u. for pJW027/pJW030/pJW033, 
pJW028/pJW031/pJW034, or pJW029/pJW032/pJW035 
using the primer pair JW_0043/JW_0010, JW_0044/
JW_0010, or JW_0045/JW_0010, respectively, and (ii) the 
backbone amplified from pJW024, pJW025, or pJW026 
for pJW027-029, pJW030-032, or pJW033-035 using the 
primer pair JW_0046/JW_0012, JW_0047/JW_0012, or 
JW_0048/JW_0012, respectively. The RBS Calculator v2.0 
[54, 55] was used to generate six synthetic RBS sequences 
with predicted translation initiation rates of 90, 9000, and 
90000 a.u. between the  PT7 promoter and pct (or VAAT ) 
start codon (Additional file 2: Figure S3).
Culture media and conditions
Culture media
For molecular cloning, seed cultures, and protein expres-
sion analysis, the Luria–Bertani (LB) medium, compris-
ing 10 g/L peptone, 5 g/L yeast extract, and 5 g/L NaCl, 
was used. For high cell density cultures, pre-cultures of 
bioreactor batch fermentations, and growth inhibition 
analysis of lactate esters, the M9 hybrid medium [10] 
with 20  g/L glucose was used. For bioreactor batch fer-
mentations, the M9 hybrid medium with 50 g/L glucose 
and 100 µL of antifoam (Antifoam 204, Sigma-Aldrich, 
MO, USA) was used. 30  µg/mL chloramphenicol (cm), 
50  µg/mL kanamycin (kan), and/or 50  µg/mL ampicil-
lin (amp) were added to the media for selection where 
applicable.
High cell density cultures
For seed cultures, 2% (v/v) of stock cells were grown 
overnight in 5  mL of LB with appropriate antibiotics. 
For pre-cultures, 1% (v/v) of seed cultures was trans-
ferred into 100  mL of LB medium in 500-mL baffled 
flasks. For main cultures, pre-cultures were aerobi-
cally grown overnight (at 37  °C, 200  rpm), centrifuged 
(4700 rpm, 10 min), and resuspended to yield an optical 
density measured at 600 nm  (OD600nm) of 3 in M9 hybrid 
medium containing appropriate concentration of isopro-
pyl-beta-d-thiogalatopyranoside (IPTG) and antibiotics. 
The resuspended cultures were distributed into 15-mL 
polypropylene centrifuge tubes (Thermo Scientific, IL, 
USA) with a working volume of 5 mL and grown for 24 h 
(h) on a 75° angled platform in a New Brunswick Excella 
E25 at 37 °C, 200 rpm. The tubes were capped to generate 
anaerobic condition. All high cell density culture studies 
were performed in biological triplicates.
pH‑controlled bioreactor batch fermentations
pH-controlled bioreactor batch fermentations were 
conducted with a Biostat B+ (Sartorius Stedim, NY, 
USA) dual 1.5-L fermentation system at a working 
volume of 1  L M9 hybrid medium. The seed and pre-
cultures were prepared as described in high cell den-
sity cultures in LB and M9 hybrid media, respectively. 
For main cultures, 10% (v/v) of pre-cultures were 
inoculated into fermentation cultures. During the fer-
mentation, to achieve high cell density, dual-phase fer-
mentation approach [25, 56], aerobic cell growth phase 
followed by anaerobic production phase, was applied. 
For the first aerobic phase, the temperature, agitation, 
and air flow rate were maintained at 37  °C, 1000  rpm, 
and 1 volume/volume/min (vvm) for 4  h, respectively. 
Then, the oxygen in the medium was purged by sparing 
nitrogen gas at 2 vvm for 2 h to generate anaerobic con-
dition. For the subsequent anaerobic phase, 0.5 mM of 
IPTG was added to induce the protein expression, and 
the culture temperature and nitrogen flow rate were 
maintained at 30  °C and 0.2  vvm, respectively. During 
the fermentation, the pH was maintained at 7.0 with 
5 M KOH and 40%  H3PO4. Bioreactor batch fermenta-
tion studies were performed in biological duplicates.
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Growth inhibition analysis of lactate esters
Seed cultures of EcDL002 were prepared as described 
in high cell density cultures. 4% (v/v) of seed cultures 
was inoculated into 100  µL of the M9 hybrid media, 
containing various concentrations (0.5–40  g/L) of lac-
tate esters including ethyl-, propyl-, butyl-, isobutyl-, 
isoamyl-, or benzyl lactate, in a 96-well microplate. 
Then, the microplate was sealed with a plastic adhesive 
sealing film,  SealPlate® (EXCEL Scientific, Inc., CA, 
USA) to prevent evaporation of lactate esters and incu-
bated at 37 °C with continuous shaking using a BioTek 
Synergy HT microplate reader (BioTek Instruments, 
Inc., VT, USA).  OD600nm was measured at 20-min inter-
vals. Growth inhibition studies of lactate esters were 
performed twice in biological triplicates (n = 6).
Protein expression and SDS‑PAGE analysis
Seed cultures were prepared as described in high cell 
density cultures. 1% (v/v) of seed cultures subsequently 
inoculated in 500-mL baffled flasks containing 100 mL 
of LB medium. Cells were aerobically grown at 37  °C 
and 200 rpm and induced at an  OD600nm of 0.6–0.8 with 
0.5 mM of IPTG. After 4 h of induction, cells were col-
lected by centrifugation and resuspended in 100 mM of 
sodium phosphate buffer (pH7.0) at the final  OD600nm 
of 10. Cell pellets were disrupted using a probe-type 
sonicator (Model 120, Fisher Scientific, NH, USA) on 
ice–water mixture. The resulting crude extracts were 
mixed with 6× sodium dodecyl sulfate (SDS) sample 
buffer, heated at 100 °C for 5 min, and then analyzed by 
SDS–polyacrylamide gel electrophoresis (SDS-PAGE, 
14% polyacrylamide gel). Protein bands were visualized 
with Coomassie Brilliant Blue staining.
Analytical methods
Determination of cell concentrations
The optical density was measured at 600  nm using a 
spectrophotometer (GENESYS 30, Thermo Scientific, IL, 
USA). The dry cell mass was obtained by multiplication 
of the optical density of culture broth with a pre-deter-
mined conversion factor, 0.48 g/L/OD.
High‑performance liquid chromatography (HPLC)
Glucose, lactate, acetate, ethanol, isobutanol, isoamyl 
alcohol, and benzyl alcohol were quantified using the 
Shimadzu HPLC system (Shimadzu Inc., MD, USA) 
equipped with the Aminex HPX-87H cation exchange 
column (BioRad Inc., CA, USA) heated at 50 °C. A mobile 
phase of 10 mN  H2SO4 was used at a flow rate of 0.6 mL/
min. Detection was made with the reflective index detec-
tor (RID) and UV detector (UVD) at 220 nm.
Gas chromatography coupled with mass spectroscopy (GC/
MS)
All esters were quantified by GC/MS. For GC/MS anal-
ysis, analytes in the supernatants were extracted with 
dichloromethane (DCM), containing pentanol as an 
internal standard, in a 1:1 (v/v) ratio for 1  h at 37  °C, 
200 rpm in 15-mL polypropylene centrifuge tubes. After 
extraction, supernatant–DCM mixtures were centrifuged 
and 5 μL of DCM extracts were injected into a gas chro-
matograph (GC) HP 6890 equipped with the mass selec-
tive detector (MS) HP 5973. For the GC system, helium 
was used as the carrier gas at a flow rate of 0.5 mL/min 
and the analytes were separated on a Phenomenex ZB-5 
capillary column (30 m × 0.25 mm × 0.25 μm). The oven 
temperature was programmed with an initial tempera-
ture of 50 °C with a 1 °C/min ramp up to 58 °C. Next, a 
25 °C/min ramp was deployed to 235 °C and then finally 
held a temperature of 300 °C for 2 min to elute any resid-
ual non-desired analytes. The injection was performed 
using a splitless mode with an initial injector temperature 
of 280 °C. For the MS system, a selected ion monitoring 
(SIM) mode was deployed to detect analytes.
The SIM parameters for detecting lactate esters 
were as follows: (i) for pentanol, ions 53.00, 60.00, and 
69.00 detected from 5.00 to 7.70  min, (ii) for ethyl lac-
tate, ions 46.00, 47.00, and 75.00 detected from 7.70 to 
10.10  min, (iii) for propyl lactate, ions 59.00, 88.00, and 
89.00 detected from 10.10 to 11.00  min, (iv) for isobu-
tyl lactate, ions 56.00, 57.00, and 59.00 detected from 
11.00 to 11.60 min, (v) for butyl lactate, ions 75.00, 91.00, 
and 101.00 detected from 11.60 to 12.30  min, (vi) for 
isoamyl lactate, ions 46.00, 73.00, 75.00 from 12.30 to 
14.50 min, and (vii) for benzyl lactate, ions 45.00, 91.00, 
and 180.00 from 14.50 to 15.08  min. The SIM param-
eters for detecting acetate esters were as follows: (i) for 
ethyl acetate, ions 45.00, 61.00, and 70.00 detected from 
4.22 to 5.35 min, (ii) for propyl acetate, ions 57.00, 59.00, 
and 73.00 detected from 5.35 to 6.40  min, (iii) for pen-
tanol, ions 53.00, 60.00, and 69.00 detected from 6.40 to 
6.60 min, (iv) for isobutyl acetate, ions 56.00, 61.00, and 
73.00 detected from 6.60 to 7.70  min, (v) for butyl ace-
tate, ions 57.00, 71.00, and 87.00 detected from 7.70 to 
9.45 min, (vi) for isoamyl acetate, ions 58.00, 70.00, and 
88.00 detected from 9.45 to 13.10 min, and (vii) for ben-
zyl acetate, ions 63.00, 107.00, and 150.00 from 13.10 to 
15.82 min.
Statistics
Statistical analysis was performed with SigmaPlot v.14 
using the two-tailed unpaired Student’s t test.
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Additional file 1: Table S1. Summary of high cell density cultures of 
EcJW101, EcJW102, EcJW103, EcJW104, and EcJW105 with addition of glu‑
cose and various alcohols after 24 h. The subscripts i and f are referred to 
the initial (0 h) and final (24 h) time of the culture, respectively. Table S2. 
Summary of titer, specific productivity, and yield of esters in high cell den‑
sity cultures of EcJW101, EcJW102, EcJW103, EcJW104, and EcJW105 with 
addition of glucose and various alcohols after 24 h. The acyl acetate and 
acyl lactate columns correspond to the acyl alcohols added. For example, 
with the exogenous addition of ethanol, the acyl acetate, and acyl lactate 
columns represent ethyl acetate, and ethyl lactate, respectively. Table S3. 
(A) Summary of high cell density cultures of EcDL002, EcJW201, and 
EcJW202 after 24 h. (B) Summary of bioreactor batch fermentation of 
EcJW201 after 18 h. The subscripts i and f are referred to the initial (0 h) 
and final (24 h) time of the culture, respectively. Table S4. Summary of 
high cell density cultures of EcJW106‑108 and EcJW203‑208 with different 
concentrations of IPTG (0.01, 0.1, or 1.0 mM) after 24 h. The subscripts i 
and f are referred to the initial (0 h) and final (24 h) time of the culture, 
respectively. Table S5. Summary of titer, specific productivity, and yield of 
esters in high cell density cultures of EcJW106‑108 and EcJW203‑208 with 
different concentrations of IPTG (0.01, 0.1, or 1.0 mM) after 24 h. Table S6. 
Summary of high cell density cultures of EcJW209‑212 with or without 
addition of ethanol (2 or 10 g/L) after 24 h. (A) OD600, pH, glucose, 
lactate, and ethanol. (B) Titer, specific productivity, and yield of esters. The 
subscripts i and f are referred to the initial (0 h) and final (24 h) time of the 
culture, respectively. Table S7. Summary of high cell density cultures of 
EcJW213‑221 after 24 h. (A) OD600, pH, glucose, lactate, and ethanol. (B) 
Titer, specific productivity, and yield of esters. The subscripts i and f are 
referred to the initial (0 h) and final (24 h) time of the culture, respectively. 
Table S8. Summary of high cell density cultures of EcJW109‑117 after 
24 h. (A) OD600, pH, glucose, lactate, and ethanol. (B) Titer, specific pro‑
ductivity, and yield of esters. The subscripts i and f are referred to the initial 
(0 h) and final (24 h) time of the culture, respectively.
Additional file 2: Figure S1. Expression of the recombinant enzymes in 
engineered E. coli strains. The positions corresponding to the overex‑
pressed proteins are indicated by arrowheads. Lane M represents protein 
ladder while lanes T, S, and I are referred to total, soluble, and insoluble 
proteins, respectively. ①~③, Pyruvate‑to‑lactate ester module; ④~⑤, 
Ethanol module; ⑥~⑩, Isobutanol module. Protein sizes were predicted 
with their amino acids sequences. Figure S2. Effect of lactate esters 
on cell growth. (A) Specific growth rates of EcDL002 with or without 
addition of lactate esters. (B) logP values of characterized lactate esters. 
The values were obtained from http://www.thego odsce ntsco mpany 
.com. (C–H) Growth curves of EcDL002 with or without addition of (C) 
n‑ethyl lactate (NEL), (D) n‑propyl lactate (NPL), (E) n‑butyl lactate (NBL), 
(F) i‑butyl lactate (IBL), (G) i‑amyl lactate (IAL), and (H) benzyl lactate (BZL). 
Figure S3. Design of (A) upstream module and (B) downstream module 
of the ethyl lactate pathway. The RBS Calculator v2.0 software was used to 
generate synthetic RBS sequences. For the upstream, four synthetic RBS 
sequences were generated with predicted translation initiation rates at 
0.33 and 0.03 between the PAY1 or PAY3 promoter and pdc start codon. 
For the downstream, six synthetic RBS sequences were generated with 
predicted translation initiation rates at 90, 9000, and 90000 a.u. between 
the PT7 promoter and pct or VAAT start codon. Figure S4. (A) Correlation 
between ester production and the amount of added ethanol in high cell 
density cultures of EcJW209‑212. (B) Correlation between ester produc‑
tion and the RBS strength for VAAT expression in high cell density culture 
of EcJW213‑221.
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